Drug intelligence / Profile preview

schizonepeta spike

Development stage
Unknown
Administration
Oral, Topical
01

Overview

Schizonepeta spike is a crude herbal drug derived from the dried flower spike of *Schizonepeta tenuifolia* Briquet (commonly known as Japanese catnip). It is a traditional medicine widely used in East Asian countries, including China, Japan, and Korea, and is officially listed in the Japanese Pharmacopoeia. The herb is traditionally utilized to promote sweating, reduce fever, detoxify, and improve skin conditions. It is commonly prescribed for the treatment of common colds, fevers, respiratory tract infections, and allergic dermatitis. In its charred form (Schizonepetae Spica Carbonisata), it is primarily used to stop bleeding, such as in bloody stool and metrorrhagia. The chemical profile of schizonepeta spike includes volatile organic compounds (such as menthone, limonene, and pulegone), flavonoids (such as apigenin-7-O-glucoside, luteolin glucoside, and hesperidin), and organic acids.

Other names
Fineleaf Schizonepeta SpikeHyung-GaeJing Jie SuiJingjie SuiKeigaiSchizonepeta tenuifolia spikeSchizonepetae Spica荊芥穗
02

Targets

CB (Cannabinoid receptors)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on schizonepeta spike.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on schizonepeta spike.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call